Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E R van Wering

Showing results (71-80 of 109) with videos related to

Pageof 11
Sort By:
Scandinavian Journal of Haematology|April 1, 1983
Immunological typing of acute lymphoblastic leukaemiaH J van der Reijden, E R van Wering, J M van de Rijn, et al.
Leukemia|September 13, 2003
Age-related patterns of immunoglobulin and T-cell receptor gene rearrangements in precursor-B-ALL: implications for detection of minimal residual diseaseV H J van der Velden, T Szczepanski, J M Wijkhuijs, et al.
European Journal of Cancer (Oxford, England : 1990)|February 1, 1996
Small influence of parental educational level on the survival of children with leukaemia in The Netherlands between 1973 and 1979J W Coebergh, A van der Does-van den Berg, W C Hop, et al.
British Journal of Haematology|August 10, 2000
Regenerating normal B-cell precursors during and after treatment of acute lymphoblastic leukaemia: implications for monitoring of minimal residual diseaseE R van Wering, B E van der Linden-Schrever, T Szczepański, et al.
The American Journal of Pediatric Hematology/Oncology|January 1, 1989
Effectiveness of rubidomycin in induction therapy with vincristine, prednisone, and L-asparaginase for standard risk childhood acute lymphocytic leukemia: results of a Dutch phase III study (ALL V). A report on behalf of the Dutch Childhood Leukemia Study Group (DCLSG)A van der Does-van den Berg, E R van Wering, S Suciu, et al.
European Journal of Cancer (Oxford, England : 1990)|March 27, 2001
A possible role for methotrexate in the treatment of childhood acute myeloid leukaemia, in particular for acute monocytic leukaemiaM G Rots, R Pieters, G Jansen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1996
High cure rate with a moderately intensive treatment regimen in non-high-risk childhood acute lymphoblastic leukemia. Results of protocol ALL VI from the Dutch Childhood Leukemia Study GroupA J Veerman, K Hählen, W A Kamps, et al.
Leukemia|November 1, 1995
In vitro chemosensitivity assessed with the MTT assay in childhood acute non-lymphoblastic leukemiaE Klumper, R Pieters, G J Kaspers, et al.
Leukemia|August 15, 2000
Application of germline IGH probes in real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemiaO J Verhagen, M J Willemse, W B Breunis, et al.
British Journal of Cancer|March 6, 2003
Cell proliferation is related to in vitro drug resistance in childhood acute leukaemiaP Kaaijk, G J L Kaspers, E R Van Wering, et al.
Pageof 11

Showing results (71-80 of 109) with videos related to

Sort By:
Pageof 11
Scandinavian Journal of Haematology|April 1, 1983
Immunological typing of acute lymphoblastic leukaemiaH J van der Reijden, E R van Wering, J M van de Rijn, et al.
Leukemia|September 13, 2003
Age-related patterns of immunoglobulin and T-cell receptor gene rearrangements in precursor-B-ALL: implications for detection of minimal residual diseaseV H J van der Velden, T Szczepanski, J M Wijkhuijs, et al.
European Journal of Cancer (Oxford, England : 1990)|February 1, 1996
Small influence of parental educational level on the survival of children with leukaemia in The Netherlands between 1973 and 1979J W Coebergh, A van der Does-van den Berg, W C Hop, et al.
British Journal of Haematology|August 10, 2000
Regenerating normal B-cell precursors during and after treatment of acute lymphoblastic leukaemia: implications for monitoring of minimal residual diseaseE R van Wering, B E van der Linden-Schrever, T Szczepański, et al.
The American Journal of Pediatric Hematology/Oncology|January 1, 1989
Effectiveness of rubidomycin in induction therapy with vincristine, prednisone, and L-asparaginase for standard risk childhood acute lymphocytic leukemia: results of a Dutch phase III study (ALL V). A report on behalf of the Dutch Childhood Leukemia Study Group (DCLSG)A van der Does-van den Berg, E R van Wering, S Suciu, et al.
European Journal of Cancer (Oxford, England : 1990)|March 27, 2001
A possible role for methotrexate in the treatment of childhood acute myeloid leukaemia, in particular for acute monocytic leukaemiaM G Rots, R Pieters, G Jansen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1996
High cure rate with a moderately intensive treatment regimen in non-high-risk childhood acute lymphoblastic leukemia. Results of protocol ALL VI from the Dutch Childhood Leukemia Study GroupA J Veerman, K Hählen, W A Kamps, et al.
Leukemia|November 1, 1995
In vitro chemosensitivity assessed with the MTT assay in childhood acute non-lymphoblastic leukemiaE Klumper, R Pieters, G J Kaspers, et al.
Leukemia|August 15, 2000
Application of germline IGH probes in real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemiaO J Verhagen, M J Willemse, W B Breunis, et al.
British Journal of Cancer|March 6, 2003
Cell proliferation is related to in vitro drug resistance in childhood acute leukaemiaP Kaaijk, G J L Kaspers, E R Van Wering, et al.
Pageof 11